CC
KURA icon

Caxton Corporation’s Kura Oncology KURA Stock Holding History

Caxton Corporation’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,406
Closed -$333K – 18
2020
Q2 		$333K Sell
20,406
-1,896
-9% -$27.4K 0.35% 14
2020
Q1 		$222K Buy
22,302
+7
+0% +$80 0.24% 14
2019
Q4 		$307K Sell
22,295
-9,272
-29% -$137K 0.3% 19
2019
Q3 		$479K Buy
31,567
+4,165
+15% +$74.1K 0.54% 14
2019
Q2 		$540K Buy
27,402
+8,128
+42% +$135K 0.61% 13
2019
Q1 		$320K Sell
19,274
-13,554
-41% -$209K 0.3% 15
2018
Q4 		$461K Sell
32,828
-1,880
-5% -$24.9K 0.56% 13
2018
Q3 		$607K Buy
34,708
+18,293
+111% +$351K 0.56% 14
2018
Q2 		$299K Buy
+16,415
New +$278K 0.11% 18

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Caxton Corporation's KURA Position: Q3 2020 in Review

Caxton Corporation sold out of Kura Oncology (KURA) in Q3 2020, closing a stake of 20,406 shares — an estimated $333K sold.

Caxton Corporation first reported a position in KURA in Q2 2018 and held it in 9 quarters. The position peaked at $607K in Q3 2018. 162 funds tracked by Wall St. Rank hold KURA as of Q3 2020.

  • Caxton Corporation reported no remaining Kura Oncology position as of Q3 2020 after selling out during the quarter.
  • Caxton Corporation sold 20,406 Kura Oncology shares in Q3 2020, an estimated $333K.
  • Caxton Corporation first reported a position in Kura Oncology in Q2 2018 and held it in 9 quarters.
  • Caxton Corporation's Kura Oncology position peaked at $607K in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2020.

Based on Caxton Corporation's 13F filing for Q3 2020, filed 16 Nov 2020.